Shih-jer Hsu

1 Chang Te Street
TPQ 10048, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

HBV RNA, HBcrAg, and HBsAg levels at year 6 do not predict HCC risk in patients with cirrhosis on long-term entecavir therapy.

Journal: Hepatology international

Published: June 09, 2026

Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablation.

Taiwan Academy of Tumor Ablation (TATA) consensus on hepatocellular carcinoma ablation.

Journal: Hepatology international

Published: September 30, 2025

IgG4-Associated Autoimmune Hepatitis: a Systematic Review.

IgG4-Associated Autoimmune Hepatitis: a Systematic Review.

Journal: Journal of gastroenterology and hepatology

Published: September 11, 2025

Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients.

Hepatitis B core-related antigen kinetics predict spontaneous HBeAg seroclearance in chronic hepatitis B patients.

Journal: Journal of gastroenterology

Published: May 21, 2025

Living donor liver transplantation in a patient with autoimmune hepatitis and systemic lupus erythematosus overlap disease.

Living donor liver transplantation in a patient with autoimmune hepatitis and systemic lupus erythematosus overlap disease.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: April 28, 2025

Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation.

Consensus Guideline of Ablation for Metastatic Liver Tumors by Taiwan Academy of Tumor Ablation.

Journal: Liver cancer

Published: February 04, 2025

Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure.

Metabolic dysfunction-associated steatotic liver disease is associated with increased risks of heart failure.

Journal: European journal of heart failure

Published: August 13, 2024

All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease.

All-cause and cause-specific mortality in patients with chronic hepatitis B and concurrent steatotic liver disease.

Journal: Journal of hepatology

Published: July 14, 2024

Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease.

Outcomes of radiofrequency ablation for hepatocellular carcinoma with concurrent steatotic liver disease.

Journal: Cancer

Published: May 27, 2024

Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C.

Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis C.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: April 20, 2024

Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.

Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.

Journal: Digestive diseases and sciences

Published: April 02, 2024

Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis B.

Pre-Existing and New-Onset Metabolic Dysfunctions Increase Cirrhosis and Its Complication Risks in Chronic Hepatitis B.

Journal: The American journal of gastroenterology

Published: January 22, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026